Evidence map›Paper›PMID 36412886›Full record

ReviewJournal of functional biomaterials2022

Review on Biocompatibility and Prospect Biomedical Applications of Novel Functional Metallic Glasses.

Michał Biały, Mariusz Hasiak, Amadeusz Łaszcz

Abstract readReview
In one paragraph

Review in Journal of functional biomaterials, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Structure and Physical Properties of MgMaterials (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michał BiałyDepartment of Mechanics, Materials and Biomedical Engineering, Wrocław University of Science and Technology, Smoluchowskiego 25, 50-370 Wroclaw, Poland.ORCID 0000-0001-6371-3743
Mariusz HasiakDepartment of Mechanics, Materials and Biomedical Engineering, Wrocław University of Science and Technology, Smoluchowskiego 25, 50-370 Wroclaw, Poland.ORCID 0000-0003-1093-6833
Amadeusz ŁaszczDepartment of Mechanics, Materials and Biomedical Engineering, Wrocław University of Science and Technology, Smoluchowskiego 25, 50-370 Wroclaw, Poland.ORCID 0000-0001-8382-4424

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The continuous development of novel materials for biomedical applications is resulting in an increasingly better prognosis for patients. The application of more advanced materials relates to fewer complications and a desirable higher percentage of successful treatments. New, innovative materials being considered for biomedical applications are metallic alloys with an amorphous internal structure called metallic glasses. They are currently in a dynamic phase of development both in terms of formulating new chemical compositions and testing their properties in terms of intended biocompatibility. This review article intends to synthesize the latest research results in the field of biocompatible metallic glasses to create a more coherent picture of these materials. It summarizes and discusses the most recent findings in the areas of mechanical properties, corrosion resistance, in vitro cellular studies, antibacterial properties, and in vivo animal studies. Results are collected mainly for the most popular metallic glasses manufactured as thin films, coatings, and in bulk form. Considered materials include alloys based on zirconium and titanium, as well as new promising ones based on magnesium, tantalum, and palladium. From the properties of the examined metallic glasses, possible areas of application and further research directions to fill existing gaps are proposed.

Indexed as

biocompatibilitybiomedicalbulk metallic glasscorrosion resistancein vitroin vivomechanical propertiesmetallic glassTi-basedZr-based

Identifiers

PMID36412886
PMCPMC9680474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.